Spring House, PA, United States of America

Steven Jacobs

USPTO Granted Patents = 40 

 

 

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 311(Granted Patents)


Location History:

  • Radnor, PA (US) (2012 - 2015)
  • Spring House, PA (US) (2013 - 2024)
  • North Wales, PA (US) (2018 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Introduction

Steven Jacobs, based in Spring House, Pennsylvania, is an accomplished inventor with a remarkable portfolio of 36 patents. His work primarily focuses on the development of innovative therapeutic molecules aimed at improving disease diagnosis and treatment. Jacobs' contributions to the field have significantly advanced medical research and technology.

Latest Patents

Among Steven Jacobs' most recent patents are the "Prostate Specific Membrane Antigen Binding Fibronectin Type III Domains" and the "CD8A-Binding Fibronectin Type III Domains." The former patent involves innovative techniques using PSMA binding FN3 domains, their conjugates, isolated nucleotides encoding these molecules, vectors, and host cells. These inventions are pivotal in generating therapeutic molecules and enhancing treatment and diagnostic methodologies for various diseases and disorders. The latter patent highlights fibronectin type III domains that specifically bind to CD8A, including related polynucleotides capable of encoding these FN3 domains, cells expressing the domains, associated vectors, and detectably labeled FN3 domains, all of which hold promise for therapeutic and diagnostic applications.

Career Highlights

Throughout his career, Steven has made significant strides in biotechnological innovations, working with renowned companies such as Janssen Biotech, Inc. and Centocor Ortho Biotech Inc. His role within these organizations has allowed him to leverage his expertise in the creation and patenting of groundbreaking medical technologies.

Collaborations

Steven Jacobs has had the opportunity to collaborate with several notable professionals in his field, including Karyn O'Neil and Michael Diem. These partnerships have been crucial in driving forward innovative research and augmenting the development of new therapeutic solutions.

Conclusion

Steven Jacobs emerges as a prolific inventor whose work continues to shape the future of therapeutic technologies. His extensive patent portfolio and collaborative efforts showcase his commitment to advancing healthcare through innovation. With each new invention, Jacobs not only contributes to scientific knowledge but also improves the prospects of treatment and diagnosis for numerous health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…